Healthcare
Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference
LOS ANGELES, July 27, 2026--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Ozan Pamir, will participate in Canaccord Genuity’s 46th Annual Growth Conference, taking place from August 11 to 13, 2026, in Boston.
About this update from Niagen Bioscience, Inc.
LOS ANGELES, July 27, 2026--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Ozan Pamir, will participate in Canaccord Genuity's 46th Annual Growth Conference, taking place from August 11 to 13, 2026, in Boston. Mr. Fried is scheduled to participate in a fireside chat on Tuesday, August 11, at 2:00 p.m. Eastern Time (11:00 a.m. Pacific Time). To register for the Niagen Bioscience fireside chat webcast, please visit www.event.summitcast.com. Mr. Fried and Mr. Pamir will also hold one-on-one meetings with institutional investors throughout the conference. To arrange a meeting, please contact your CG representative or email [email protected]. A replay of the fireside chat webcast will be available on the Niagen Bioscience Investor Relations website, www.investors.niagenbioscience.com, following the event. For additional information on Niagen Bioscience, visit www.niagenbioscience.com. About Niagen Bioscience Niagen Bioscience, Inc. (NASDAQ: NAGE) is the global authority in healthy aging and NAD+ (nicotinamide adenine dinucleotide) science. As a trusted pioneer of NAD+ discoveries, Niagen Bioscience™ is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. The Niagen Bioscience team, composed of world-renowned scientists, works with independent investigators from esteemed universities and research institutions around the globe to uncover the full potential of NAD+. A vital coenzyme found in every cell of the human body, NAD+ declines with age and exposure to everyday lifestyle stressors. NAD+ depletion is a key contributor to age-related changes in health and vitality. Distinguished by state-of-the-art laboratories, rigorous scientific and quality protocols, and collaborations with leading research institutions worldwide, Niagen Bioscience sets the gold standard for research, quality, and innovation. There's a better way to age. At the heart of its clinically proven product portfolio is Niagen® (patented nicotinamide riboside, or NR), the most efficient, well-researched, and high-quality NAD+ booster available. Niagen powers the Company's consumer supplement, Tru Niagen®, the number one NAD+ boosting oral suppl...
View stock analysis, news, and events for Niagen Bioscience, Inc.